Article Text

Download PDFPDF
CASE REPORT
Intrapancreatic accessory spleen: an enigmatic entity
  1. Namita Chavan1,
  2. Gunjan Shailesh Desai1,
  3. Chandralekha Tampi2 and
  4. Prasad Wagle1
  1. 1 Department of Gastrointestinal Surgery, Lilavati Hospital and Research Centre, Mumbai, India
  2. 2 Department of Pathology, Lilavati Hospital and Research Centre, Mumbai, India
  1. Correspondence to Dr Gunjan Shailesh Desai, desaigunjan526{at}gmail.com

Abstract

Solitary hypervascular lesion in the distal body/tail of pancreas in a patient with non-specific abdominal symptoms is a diagnostic challenge. Neuroendocrine neoplasm (NEN) and metastasis from renal cell carcinoma are the most common differentials and intrapancreatic accessory spleen (IPAS) is the rarest of its differential diagnosis. We present, here, a case of a 56-year-old man with a space-occupying lesion in body/tail of pancreas that was preoperatively diagnosed as a NEN based on elevated chromogranin levels and hyperenhancing lesion on contrast-enhanced CT scan. He underwent a spleen-preserving distal pancreatectomy. The final histopathology revealed an IPAS.

  • radiology (diagnostics)
  • pancreas and biliary tract
  • neuroendocrinology
  • pancreatic cancer
  • surgical oncology

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors GSD and NC planned and carried out the review of literature for the case report under conception and design of article by CT and PW. CT provided the pathological inputs. All authors have worked towards the literature review and the management plan of the patient. The report was written by GSD and NC under the critical supervision and inputs of CT and PW.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.